- Anileridine
-
Anileridine Systematic (IUPAC) name Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate Clinical data AHFS/Drugs.com monograph Pregnancy cat. ? Legal status ℞-only (CA) Schedule II (US) Routes Tablets, injection Pharmacokinetic data Protein binding > 95% Metabolism Hepatic Identifiers CAS number 144-14-9 ATC code N01AH05 PubChem CID 8944 DrugBank APRD00741 ChemSpider 8600 UNII 71Q1A3O279 KEGG D02941 ChEBI CHEBI:61203 ChEMBL CHEMBL1201347 Chemical data Formula C22H28N2O2 Mol. mass 352.47 g/mol SMILES eMolecules & PubChem Physical data Melt. point 83 °C (181 °F) (what is this?) (verify) Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s[1]. It differs from meperidine (Demerol) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.
Anileridine is no longer manufactured in the US or Canada.[2]
Administration
Pharmacokinetics
Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.[4] It is mostly metabolized by the liver.
References
- ^ US Patent 2897204
- ^ "Discontinued Prescription Drug Products". Canadian Pharmacists' Association. http://www.pharmacists.ca/content/hcp/tools/drugnews/discontinued.htm. Retrieved 28 July 2008.
- ^ "Pharmaceutical Information - LERITINE". RxMed. http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20%28General%20Monographs-%20L%29/LERITINE.html. Retrieved 16 June 2010.
- ^ "Anileridine Consumer Information". MedicineNet. http://www.medicinenet.com/anileridine-oral_tablet/article.htm. Retrieved 28 July 2008.
Anesthetic: General anesthetics (N01A) Inhalation OthersInjection OthersThis drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.